Literature DB >> 15705891

Identification of OTX2 as a medulloblastoma oncogene whose product can be targeted by all-trans retinoic acid.

Chunhui Di1, Shaoxi Liao, David C Adamson, Timothy J Parrett, Daniel K Broderick, Qun Shi, Christoph Lengauer, Jordan M Cummins, Victor E Velculescu, Daniel W Fults, Roger E McLendon, Darell D Bigner, Hai Yan.   

Abstract

Through digital karyotyping of permanent medulloblastoma cell lines, we found that the homeobox gene OTX2 was amplified more than 10-fold in three cell lines. Gene expression analyses showed that OTX2 transcripts were present at high levels in 14 of 15 (93%) medulloblastomas with anaplastic histopathologic features. Knockdown of OTX2 expression by siRNAs inhibited medulloblastoma cell growth in vitro, whereas pharmacologic doses of all-trans retinoic acid repressed OTX2 expression and induced apoptosis only in medulloblastoma cell lines that expressed OTX2. These observations suggest that OTX2 is essential for the pathogenesis of anaplastic medulloblastomas and that these tumors may be amenable to therapy with all-trans-retinoic acid.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15705891

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  68 in total

1.  Temporal and spatial delineation of mouse Otx2 functions by conditional self-knockout.

Authors:  Nicolas Fossat; Gilles Chatelain; Gilbert Brun; Thomas Lamonerie
Journal:  EMBO Rep       Date:  2006-07-14       Impact factor: 8.807

Review 2.  Learning to see again: biological constraints on cortical plasticity and the implications for sight restoration technologies.

Authors:  Michael Beyeler; Ariel Rokem; Geoffrey M Boynton; Ione Fine
Journal:  J Neural Eng       Date:  2017-06-14       Impact factor: 5.379

3.  HDMX regulates p53 activity and confers chemoresistance to 3-bis(2-chloroethyl)-1-nitrosourea.

Authors:  Genglin Jin; Stephen Cook; Bo Cui; William C Chen; Stephen T Keir; Patrick Killela; Chunhui Di; Cathy A Payne; Simon G Gregory; Roger McLendon; Darell D Bigner; Hai Yan
Journal:  Neuro Oncol       Date:  2010-05-14       Impact factor: 12.300

4.  Expression of the homeobox genes OTX2 and OTX1 in the early developing human brain.

Authors:  Karen B Larsen; Melissa C Lutterodt; Kjeld Møllgård; Morten Møller
Journal:  J Histochem Cytochem       Date:  2010-03-30       Impact factor: 2.479

Review 5.  Polycomb group proteins: navigators of lineage pathways led astray in cancer.

Authors:  Adrian P Bracken; Kristian Helin
Journal:  Nat Rev Cancer       Date:  2009-11       Impact factor: 60.716

6.  Clinico-pathological description of three paediatric medulloblastoma cases with MLL2/3 gene mutations.

Authors:  G Y López; G A Grant; H E Fuchs; L G Leithe; S Gururangan; D D Bigner; H Yan; R E McLendon; Y He
Journal:  Neuropathol Appl Neurobiol       Date:  2014-02       Impact factor: 8.090

Review 7.  Pediatric brain tumors: current treatment strategies and future therapeutic approaches.

Authors:  Sabine Mueller; Susan Chang
Journal:  Neurotherapeutics       Date:  2009-07       Impact factor: 7.620

Review 8.  Aggressive infantile embryonal tumors.

Authors:  Tobey J MacDonald
Journal:  J Child Neurol       Date:  2008-10       Impact factor: 1.987

9.  The transcription factor Cux1 in cerebellar granule cell development and medulloblastoma pathogenesis.

Authors:  Sabine Topka; Alexander Glassmann; Gunnar Weisheit; Ulrich Schüller; Karl Schilling
Journal:  Cerebellum       Date:  2014-12       Impact factor: 3.847

Review 10.  Biological background of pediatric medulloblastoma and ependymoma: a review from a translational research perspective.

Authors:  Judith M de Bont; Roger J Packer; Erna M Michiels; Monique L den Boer; Rob Pieters
Journal:  Neuro Oncol       Date:  2008-08-01       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.